These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 2477855

  • 1. Effects of PGD2, PGE1, and PGI2-analogues on PGDF-release and aggregation of human gelfiltered platelets.
    Stürzebecher S, Nieuweboer B, Matthes S, Schillinger E.
    Prog Clin Biol Res; 1989; 301():365-9. PubMed ID: 2477855
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
    Nakagawa S, Matsui N, Akiba T, Shinoda T, Fukudome Y, Ozawa K, Baba M, Nakanishi T, Takeuchi J.
    Proc Eur Dial Transplant Assoc; 1981; 18():117-21. PubMed ID: 7036145
    [Abstract] [Full Text] [Related]

  • 8. Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease.
    Fitscha P, Kaliman J, Sinzinger H.
    Am J Hematol; 1985 May; 19(1):13-9. PubMed ID: 3885723
    [Abstract] [Full Text] [Related]

  • 9. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
    Fisher CA, Kappa JR, Sinha AK, Cottrell ED, Reiser HJ, Addonizio VP.
    J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. PGI2 and PGE1 induce morphological alterations in human platelets similar to those of the initial phase of activation.
    Zilla P, Groscurth P, Varga G, Fischlein T, Fasol R.
    Exp Hematol; 1987 Aug; 15(7):741-9. PubMed ID: 3301381
    [Abstract] [Full Text] [Related]

  • 14. Prostaglandins and platelet aggregation.
    Smith JB.
    Acta Med Scand Suppl; 1981 Aug; 651():91-9. PubMed ID: 7034481
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Influences of prostaglandins on electrophoretic mobility and aggregation of rabbit platelets.
    Takano S, Itagaki S, Sakurai K, Suzuki T.
    Prostaglandins; 1980 Sep; 20(3):579-86. PubMed ID: 6999547
    [Abstract] [Full Text] [Related]

  • 17. Refractoriness of diabetic platelets to inhibitory prostaglandins.
    Lagarde M, Berciaud P, Burtin M, Dechavanne M.
    Prostaglandins Med; 1981 Oct; 7(4):341-7. PubMed ID: 6273957
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of PGI2 and di-butyryl cyclic-AMP on platelets exposed to shear stress.
    Hardwick RA, Hellums JD, Peterson DM, Moake J, Olson J.
    Trans Am Soc Artif Intern Organs; 1981 Oct; 27():192-6. PubMed ID: 6277071
    [No Abstract] [Full Text] [Related]

  • 20. Further studies with 5E and 5Z analogues of PGI2 in platelets and vasculature.
    Oliva D, Giovanazzi S, Lograno M, Mongelli N, Corsini A, Fumagalli R, Nicosia S.
    Adv Prostaglandin Thromboxane Leukot Res; 1989 Oct; 19():172-5. PubMed ID: 2526466
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.